A prolactinoma is a noncancerous pituitary tumor that causes excess secretion of the hormone prolactin. Prolactin is a hormone that causes secretion of milk from the breasts during nursing. It is also involved in the control of sexual desire.
Alternative Names: Prolactinoma - females; Adenoma - secreting
Causes, incidence, and risk factors:
Prolactin is a hormone that induces lactation or milk production. The size of the prolactinoma correlates with the excess prolactin level; the larger the tumor, the higher the level of prolactin that is secreted.
Prolactinoma is the most common type of pituitary adenoma and is also referred to as a prolactin-secreting adenoma of the pituitary. These tumors account for at least 30% of all pituitary adenomas.
At least half of all prolactinomas are microadenomas. Microprolactinomas are more common in women. Larger tumors, called macroprolactinomas, are more common in men. Many of the smaller tumors do not progress to larger tumors.
Prolactinomas occur most commonly in those under 40 years old. They are rare in children. These tumors are about fives times as common in women as men. In women, prolactinomas typically cause amenorrhea (lack of menstruation) and galactorrhea (milk production from the breasts, not associated with pregnancy) and occur in young patients. By contrast, prolactinomas in men occur in older patients and can grow to a large size before any symptoms occur.
Note: there may be no symptoms, particularly in men.
Signs and tests:
In women, the symptoms of infertility, irregular menstruation, loss of sexual interest, and milk flow not related to childbirth or nursing can be improved with treatment. Men should be treated when decreased sexual drive, infertility, or impotence occur.
Bromocriptine, pergolide, and cabergoline are drugs that reduce prolactin levels in both men and women. Once started, these drugs must be continued for life. If the drug is stopped, the tumor will rapidly grow back. Most people respond to these drugs, although failure is more likely with large prolactinomas. Using bromocriptine over time can reduce the chance of a cure using surgical removal. Therefore, if surgery is to be done, it is best to perform the surgery during the first 6 months of using this drug.
Surgery may be needed in the case of a prolactinoma that is not controlled by medication, and in patients who have trouble tolerating medication side effects. Radiotherapy (conventional radiation or gamma knife) is usually for patients who have persistent and progressive (worsening) prolactinoma after trying both medication and surgery.
The outlook depends heavily on the success of medical and surgical therapies. Tests to scan for recurrence following treatment are important.
Tumor regrowth is the main complication. If untreated, tumor growth may result in permanent vision loss, including blindness, because large tumors in this area often press on the nerves involved in vision.
Calling your health care provider:
See your health care provider if symptoms suggestive of prolactinoma develop.
If you have had a prolactinoma in the past, call your health care provider if you experience recurrence of the symptoms.